Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +739.84%
#3 ADO Protocol ADO Protocol +101.78%
#4 Cortex Cortex +93.60%
#5 Ontology Gas Ontology Gas +74.05%
#6 Kinesis Silver Kinesis Silver +53.19%
#7 Magma Finance Magma Finance +28.58%
#8 OpenEden OpenEden +27.53%
#9 PondCoin PondCoin +25.81%
#10 Pons Pons +24.43%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Viking Therapeutics, Inc. Viking Therapeutics, Inc.

Viking Therapeutics, Inc.

VKTX
Classifica tra le azioni #4217
Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting both non-alcoholic steatohepatitis (NASH) in biopsy-confirmed patients and non-alcoholic fatty liver disease (NAFLD). Viking's pipeline also features VK5211, an oral, non-steroidal selective androgen receptor modulator undergoing Phase II studies for individuals recuperating from non-elective hip fracture surgery. Additionally, VK0612, an oral drug candidate for type 2 diabetes, is poised to enter Phase IIb trials. The firm is also developing VK0214, another orally active, tissue and receptor-selective TRß agonist, specifically aimed at X-linked adrenoleukodystrophy. Founded in 2012, Viking Therapeutics is headquartered in San Diego, California.
Prezzo delle azioni
$34.37
Capitalizzazione di mercato
$4.01B
Variazione (1 giorno)
0.59%
Variazione (1 anno)
31.99%
Paese
US
Scambia Viking Therapeutics, Inc. (VKTX)

Categoria

Healthcare
Storico del prezzo dell'azione per Viking Therapeutics, Inc. (VKTX)
Prezzo di chiusura più alto: $33.93 il 2026-08-01

Prezzo di chiusura più basso: $8.59 il 2015-04-01
Storico del prezzo dell'azione di Viking Therapeutics, Inc. dal 2015 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -9.08%
2025 -20.83%
2024 152.59%
2023 215.71%
2022 16.84%
2021 -21.08%
2020 -20.48%
2019 -10.51%
2018 130.53%
2017 246.93%
2016 -60.36%
2015 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $549.38 41.89%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 47.72%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.35 499.86%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.62 -12.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $764.47 6.25%
CH